← Return to 1st appointment w/doc tomorrow. Any "must ask" questions ?

Discussion
Comment receiving replies
@jnmy

@pacathy
You may find this article interesting.

Open access
Brensocatib in non-cystic fibrosis bronchiectasis: ASPEN protocol and baseline characteristics
James D. Chalmers Pierre-Régis Burgel Charles L. Daley Show More
ERJ Open Research 2024 10(4): 00151-2024; DOI: https://doi.org/10.1183/23120541.00151-2024

Jump to this post


Replies to "@pacathy You may find this article interesting. Open access Brensocatib in non-cystic fibrosis bronchiectasis: ASPEN protocol..."

I looked through the whole study. But it is not clear to me what the conclusion was with Pseudomonas and Brensocatib. Is anyone else better at interpreting studies in a nutshell?

Thanks. I've read the Willow and Aspen studies, but am curious about what the practitioners are thinking. I'm always curious though. : )